Zobrazeno 1 - 3
of 3
pro vyhledávání: '"William Wei‐Han Chen"'
Autor:
Zoe White, Marine Theret, Nadia Milad, Lin Wei Tung, William Wei‐Han Chen, Martin G. Sirois, Fabio Rossi, Pascal Bernatchez
Publikováno v:
Journal of Cachexia, Sarcopenia and Muscle, Vol 13, Iss 1, Pp 544-560 (2022)
Abstract Background Muscular dystrophy (MD) causes muscle wasting and is often lethal in patients due to a lack of proven therapies. In contrast, mouse models of MD are notoriously mild. We have previously shown severe human‐like muscle pathology i
Externí odkaz:
https://doaj.org/article/1734f6d867e74b1188de0ce7c5e14a22
Autor:
Zoe White, Nadia Milad, Arash Y Tehrani, William Wei-Han Chen, Graham Donen, Stephanie L Sellers, Pascal Bernatchez
Publikováno v:
PLoS ONE, Vol 14, Iss 8, p e0220903 (2019)
There is no cure or beneficial management option for Limb-Girdle muscular dystrophy (MD) type 2B (LGMD2B). Losartan, a blood pressure (BP) lowering angiotensin II (AngII) receptor type 1 (ATR1) blocker (ARB) with unique anti-transforming growth facto
Externí odkaz:
https://doaj.org/article/be524c11a5c04573acfffd11c054bb2a
Autor:
Pascal Bernatchez, Stephanie L. Sellers, William Wei-Han Chen, Nadia Milad, Zoe White, Arash Y. Tehrani, Graham Donen
Publikováno v:
PLoS ONE, Vol 14, Iss 8, p e0220903 (2019)
PLoS ONE
PLoS ONE
There is no cure or beneficial management option for Limb-Girdle muscular dystrophy (MD) type 2B (LGMD2B). Losartan, a blood pressure (BP) lowering angiotensin II (AngII) receptor type 1 (ATR1) blocker (ARB) with unique anti-transforming growth facto
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::68185d6f7c6bbeb39d403b9b5e7c973e
https://doaj.org/article/be524c11a5c04573acfffd11c054bb2a
https://doaj.org/article/be524c11a5c04573acfffd11c054bb2a